The role of endogenous heme synthesis and degradation domain cysteines in cellular iron-dependent degradation of IRP2

Blood Cells, Molecules, and Diseases

Volumn 31, Issue 2, 2003, Pages 247-255

  Bourdon, Emmanuel ^a,c   Kang, Dae Kyung ^b,d   Ghosh, Manik C ^a   Drake, Steven K ^a   Wey, Jane ^a   Levine, Rodney L ^b   Rouault, Tracey A ^a,e  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d 374 4 Easy Bio Easy Bio System   (South Korea)

^e NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE DERIVATIVE; DEFEROXAMINE MESYLATE; IRON; IRON REGULATORY PROTEIN 2; MUTANT PROTEIN; NITROPRUSSIDE SODIUM; OXYGEN; REGULATOR PROTEIN; SUCCINYLACETONE; UNCLASSIFIED DRUG; COBALT CHLORIDE; CYSTEINE; HEME; IRON CHELATE; IRON REGULATORY FACTOR; ISOPROTEIN; NITRIC OXIDE; RECOMBINANT PROTEIN;

ARTICLE; BINDING SITE; CELL FUNCTION; CELL LINE; HEME SYNTHESIS; HUMAN; HUMAN CELL; IN VITRO STUDY; IRON METABOLISM; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN STABILITY; SITE DIRECTED MUTAGENESIS; WILD TYPE; CELL COMPOSITION; CONTROLLED STUDY; EMBRYO; MUTAGENESIS; PROTEIN FUNCTION;

MAMMALIA;

EID: 0348111398     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1079-9796(03)00161-X     Document Type: Article

References (25)

1. Gruer M.J., Artymiuk P.J., Guest J.R. The aconitase family three structural variations on a common theme . Trends Biochem. Sci. 22:1997;3-6.
2. LaVaute T., Smith S., Cooperman S., et al. Targeted deletion of iron regulatory protein 2 causes misregulation of iron metabolism and neurodegenerative disease in mice. Nat. Genet. 27:2001;209-221.
3. Iwai K., Klausner R.D., Rouault T.A. Requirements for iron-regulated degradation of the RNA binding protein, iron regulatory protein 2. EMBO J. 14:1995;5350-5357.
4. Allerson C.R., Martinez A., Yikilmaz E., Rouault T.A. A high-capacity RNA affinity column for the purification of human IRP1 and IRP2 overexpressed in Pichia pastoris. RNA. 9:2003;364-374.
5. Iwai K., Klausner R.D., Rouault T.A. Requirements for iron-regulated degradation of the RNA binding protein, iron regulatory protein 2. EMBO J. 14:1995;5350-5357.
6. Iwai K., Drake S.K., Wehr N.B., et al. Iron-dependent oxidation, ubiquitination, and degradation of iron regulatory protein 2 implications for degradation of oxidized proteins . Proc. Natl. Acad. Sci. USA. 95:1998;4924-4928.
7. Beckman K.B., Ames B.N. The free radical theory of aging matures. Physiol. Rev. 78:1998;547-581.
8. D.K. Kang, J. Jeong, S.K. Drake, N. Wehr, T.A. Rouault, R.L. Levine, Iron-regulatory protein 2 as iron sensor: iron-dependent oxidative modification ofcysteine. J. Biol. Chem. (2003) 14857-14864.
9. Hanson E.S., Foot L.M., Leibold E.A. Hypoxia post-translationally activates iron-regulatory protein 2. J. Biol. Chem. 274:1999;5047-5052.
10. Kim S., Ponka P. Nitrogen monoxide-mediated control of ferritin synthesis implications for macrophage iron homeostasis . Proc. Natl. Acad. Sci. USA. 99:2002;12214-12219.
11. Recalcati S., Taramelli D., Conte D., Cairo G. Nitric oxide-mediated induction of ferritin synthesis in J774 macrophages by inflammatory cytokines role of selective iron regulatory protein-2 downregulation . Blood. 91:1998;1059-1066.
12. 2 sensing . Science. 292:2001;464-468.
13. J.M. Stevens, O. Daltrop, C.W. Higham, S.J. Ferguson, Interaction of heme with variants of the heme chaperone CcmE carrying active site mutations and a cleavable N-terminal His tag. J. Biol. Chem. (2003) 20500-20506.
14. Kim S., Ponka P. Control of transferrin receptor expression via nitric oxide-mediated modulation of iron-regulatory protein 2. J. Biol. Chem. 274:1999;33035-33042.
15. Kleschyov A.L., Sedov K.R., Mordvintcev P.I., Vanin A.F. Biotransformation of sodium nitroprusside into dinitrosyl iron complexes in tissue of ascites tumors of mice. Biochem. Biophys. Res. Commun. 202:1994;168-173.
16. 2) control mammalian iron metabolism by different pathways. Mol. Cell Biol. 16:1996;3781-3787.
17. Phillips J.D., Kinikini D.V., Yu Y., Guo B., Leibold E.A. Differential regulation of IRP1 and IRP2 by nitric oxide in rat hepatoma cells. Blood. 87:1996;2983-2992.
18. Kim S., Ponka P. Effects of interferon-gamma and lipopolysaccharide on macrophage iron metabolism are mediated by nitric oxide-induced degradation of iron regulatory protein 2. J. Biol. Chem. 275:2000;6220-6226.
19. Goessling L.S., Mascotti D.P., Thach R.E. Involvement of heme in the degradation of iron-regulatory protein 2. J. Biol. Chem. 273:1998;12555-12557.
20. Yamanaka K., Ishikawa H., Megumi Y. Identification of the ubiquitin-protein ligase that recognizes oxidized IRP2. Nat. Cell Biol. 5:2003;336-340.
21. Butt J., Kim H.Y., Basilion J.P. Differences in the RNA binding sites of iron regulatory proteins and potential target diversity. Proc. Natl. Acad. Sci. USA. 93:1996;4345-4349.
22. Guo B., Yu Y., Leibold E.A. Iron regulates cytoplasmic levels of a novel iron-responsive element-binding protein without aconitase activity. J. Biol. Chem. 269:1994;24252-24260.
23. Braun R.D., Lanzen J.L., Snyder S.A., Dewhirst M.W. Comparison of tumor and normal tissue oxygen tension measurements using OxyLite or microelectrodes in rodents. Am. J. Physiol. Heart Circ. Physiol. 280:2001;H2533-2544.
24. Yuan Y., Hilliard G., Ferguson T., Millhorn D.E. Cobalt inhibits the interaction between hypoxia inducible factor-alpha and von Hippel-Lindau protein by direct binding to hypoxia inducible factor-alpha. J. Biol. Chem. 278:2003;15911-15916.
25. Shan Y., Pepe J., Lambrecht R.W., Bonkovsky H.L. Mapping of the chick heme oxygenase-1 proximal promoter for responsiveness to metalloporphyrins. Arch. Biochem. Biophys. 399:2002;159-166.